Biotech Investment Analyst – Drug Asset and Company Assessment

This is a fully remote position, open to applicants in United States.

📋 Description

• Develop and evaluate rubrics that assess commercial drugs and drug development initiatives.

• Conduct comprehensive evaluations of the company and its assets, including mechanisms, clinical data, competitive landscape, and value drivers.

• Assess the robustness of investment theses, identifying any weak, overly confident, or absent assumptions.

• Implement evaluations across a pilot group of around 5–10 companies.

• Contribute to enhancing AI-driven assessments of drugs and drug development programs.

⛳️ Requirements

• Biotech or healthcare investment analyst based in the United States with experience in specialist funds.

• Knowledge of biotech and pharmaceutical development programs.

• Capable of conducting end-to-end assessments of drug assets and the companies that develop them.

• Over 5 years of experience in evaluating biotech or pharmaceutical companies or assets.

• Availability for approximately 10–20 hours over a 1–2 week pilot period.

• Must reside in the United States.

🏝️ Benefits

• Compensated pilot engagement.

• Opportunity for ongoing collaboration for high-performing contributors.